pubmed-article:8221570 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8221570 | lifeskim:mentions | umls-concept:C1336708 | lld:lifeskim |
pubmed-article:8221570 | lifeskim:mentions | umls-concept:C0025545 | lld:lifeskim |
pubmed-article:8221570 | lifeskim:mentions | umls-concept:C0013203 | lld:lifeskim |
pubmed-article:8221570 | lifeskim:mentions | umls-concept:C1707520 | lld:lifeskim |
pubmed-article:8221570 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:8221570 | pubmed:issue | 10 | lld:pubmed |
pubmed-article:8221570 | pubmed:dateCreated | 1993-12-6 | lld:pubmed |
pubmed-article:8221570 | pubmed:abstractText | Metallothioneins (MT) are endogenous metalloproteins involved in the homeostasis of essential metals and detoxification of toxic metals. Some recent experimental studies suggested tumor resistance to cisdiamminedichloroplatin may be associated with overexpression of MT in the tumor. | lld:pubmed |
pubmed-article:8221570 | pubmed:language | eng | lld:pubmed |
pubmed-article:8221570 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8221570 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8221570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8221570 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8221570 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8221570 | pubmed:month | Nov | lld:pubmed |
pubmed-article:8221570 | pubmed:issn | 0008-543X | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:CherianM GMG | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:BanerjeeDD | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:DIEUH AHA | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:ChauvinP JPJ | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:KadhimS ASA | lld:pubmed |
pubmed-article:8221570 | pubmed:author | pubmed-author:KontozoglouT... | lld:pubmed |
pubmed-article:8221570 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8221570 | pubmed:day | 15 | lld:pubmed |
pubmed-article:8221570 | pubmed:volume | 72 | lld:pubmed |
pubmed-article:8221570 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8221570 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8221570 | pubmed:pagination | 3029-35 | lld:pubmed |
pubmed-article:8221570 | pubmed:dateRevised | 2010-3-24 | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:meshHeading | pubmed-meshheading:8221570-... | lld:pubmed |
pubmed-article:8221570 | pubmed:year | 1993 | lld:pubmed |
pubmed-article:8221570 | pubmed:articleTitle | Metallothionein in testicular germ cell tumors and drug resistance. Clinical correlation. | lld:pubmed |
pubmed-article:8221570 | pubmed:affiliation | Division of Urology, University of Western Ontario, London, Canada. | lld:pubmed |
pubmed-article:8221570 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8221570 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8221570 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8221570 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8221570 | lld:pubmed |